None listed
Conditions
Interventions
Drug : At the time of registration, patients were randomly allocated to either group. They were randomized by a computer generated list and were provided with written instructions. The patients were n
Sponsors
Chosun University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria 1) All patients aged between 19 and 75 years 2) Patients who were scheduled to undergo colonoscopy 3) Patients who voluntarily decide to participate in this clinical trial and who have consented in writing
Exclusion criteria
Exclusion criteria: Exclusion criteria 1) Patient who had history of gastric or colon surgery, acute abdomen 2) Suspected bowel perforation or obstruction, inflammatory bowel disease, gastric ulcer, gastric paralysis 3) History of chronic kidney disease, congestive heart failure 4) Hypersensitivity 5) Cancer 6) Severe constipation or take constipation medication within 3 months 7) Colonoscopy for polypectomy 8) Refused informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Efficacy of bowel cleansing by using the Harefield Cleansing Scale | — |
Secondary
| Measure | Time frame |
|---|---|
| Harefield Cleansing Scale at each segment of colon;Adenoma detection rate;Compliance (Success of intake, palatability, amount of agent, preference;Patient adverse events(Nausea, vomiting, abdominal pain, dehydration, sleep disturbance, headache) | — |
Countries
Korea, Republic of
Contacts
Public ContactSeong Jung Kim
Chosun University
Outcome results
None listed